Southeast Asian Affairs, of which there are now twenty-five in the series, is a review of significant developments and trends in the region, with particular emphasis on ASEAN countries. The ...
In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), significantly improving access to diabetes treatment. The glucagon-like peptide-1 ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...
Elite Pharmaceuticals announced the launch of its generic version of Vyvanse® (Lisdexamfetamine Disylate) in various strengths, targeting the ADHD treatment market. The product, which is marketed ...
The incoming president has a lot of power and being able to get in on the ground floor through a large contribution to his inaugural committee is a way for megadonors and corporate interests to be ...
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who are 10 years old and up with Type 2 diabetes. The liraglutide ...
Dragon Ball has revealed the late Akira Toriyama’s original designs for new Majin Buu successors, Kuu and Duu Dragon Ball’s new Super Majin Rymus is a big step forward in filling out Dragon ...
See the top gainers, losers, invest and get updated what's happening in the crypto market ...
Manufacturers must look at potential return on investment when considering making a product. Generic manufacturers particularly look at market size, patents that are expiring, and whether other ...
the trade associations for researchbased and generic pharmaceutical manufacturers and for distributors, group purchasing organizations (GPOs), the American Hospital Association (AHA), the ...